IP Library › Assignment 031144/0829
Patent Assignment
Reel/Frame 031144/0829

Assignment of Assignor's Interest

Recorded: 2013-09-05 Pages: 4
Assignor
PDL BIOPHARMA, INC.
Executed: 2009-10-27
Assignee
FACET BIOTECH CORPORATION
1400 SEAPORT BLVD., REDWOOD CITY, CALIFORNIA, 94063
Covered Property (1)
Use of Anti-CS1 Antibodies for Treatment of Rare Lymphomas
Patent: 8,603,477 →
Application: 13/126,754 →
Publication: US 2011/0206701
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Feb 18, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029825/0070 →
Assignment of Assignor's Interest Sep 5, 2013
From: AFAR, DANIEL
To: PDL BIOPHARMA, INC.
Reel/Frame 031144/0351 →
Assignment of Assignor's Interest Sep 5, 2013
From: AFAR, DANIEL
To: FACET BIOTECH CORPORATION
Reel/Frame 031145/0193 →
Assignment of Assignor's Interest Sep 5, 2013
From: HSI, ERIC
To: THE CLEVELAND CLINIC
Reel/Frame 031169/0882 →
Change of Name Sep 5, 2013
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 031169/0958 →
Assignment of Assignor's Interest Sep 5, 2013
From: HSI, ERIC
To: THE CLEVELAND CLINIC
Reel/Frame 031170/0083 →